Uterine cancer Doctors Abroad — Page 4

Uzm. Dr. Erkan Göcen is a Radiation Oncology Specialist at Çerkezköy Private Optimed Hospital (Optimed Health Group). He graduated from İstanbul University, İstanbul Faculty of Medicine (Çapa) in 2003.

Career: He trained and practiced in Radiation Oncology from 2010 to 2012. He worked in public and private health institutions from 2012 to 2016. He served in the private medical sector as a Radiation Oncology Specialist from 2016 to 2023. He has been at Optimed Hospital since 2024.

Clinical interests: cancers of the brain, head and neck, esophagus, stomach, colorectal, pancreas, prostate, bladder, lung, soft tissues (sarcomas), skin, uterus and cervix, and breast. Affiliations: Turkish Society for Radiation Oncology (TROD) and Tekirdağ Medical Chamber. Languages: English and Turkish.

The doctor graduated from Marmara University Faculty of Medicine and completed specialization at Kartal Dr. Lütfi Kırdar Training and Research Hospital. Further expertise was gained through a minor in Medical Oncology at Kocaeli University Faculty of Medicine.

Professional experience includes roles in Internal Medicine at Oltu State Hospital and Medical Oncology at Kocaeli State Hospital. The doctor has also contributed to the field at Marmara University Pendik Training and Research Hospital and Medistate Kavacik Hospital.

Associate Professor Duygu Derin is a leading medical oncologist at Liv Hospital Ulus with a reputation for managing complex gynecologic neoplasms. She is a published expert in treating malignancies throughout Europe and Turkey.

• Specialises in systemic treatment for uterine and ovarian cancers
• Integrates the latest drug therapies as an active ESMO member
• Author of over 30 scientific papers on modern malignancy treatments
• Trained in internal medicine and senior oncology at major research centres
• Focuses on complex medical care for gynaecological cancer patients

Professor Lee Kwang Beom specialises in treating uterine cancer through laparoscopic surgery – a minimally invasive approach using small incisions for less scarring and quicker healing.

• Performs laparoscopic operations at Gachon University Gil Medical Center
• Expert in oncogynecology for malignant tumours of the female reproductive system
• Professor at Gachon University – one of South Korea's major medical training institutions
• Dedicated focus on surgical management of uterine and gynaecological cancers

Professor Turkan Ozturk Topcu brings international expertise to Biruni University Hospital, having completed fellowships at the world-leading MD Anderson Cancer Center in the USA.

• Specialises in gynaecological oncology, focusing on uterine and ovarian cancer care
• Completed advanced training at Sunnybrook Odette Cancer Center in Canada
• Recognised member of the American Society of Clinical Oncology (ASCO)
• Practises at Biruni University Hospital, a major academic and research institution
• Maintains international standards as a member of the European Society for Medical Oncology

Associate Professor Murat Ayhan is a senior medical oncologist at Liv Hospital Vadistanbul, specialising in systemic drug therapies for complex gynaecological cancers.

• Expertise in molecular oncology – uses genetic profiling to target uterine cancer cells with precise drug therapies
• Oversees clinical research into new immunotherapy and targeted agent protocols for advanced-stage cases
• Specialises in managing chemotherapy side effects and rapid drug desensitisation for sensitive patients
• Published author on oncological emergencies and targeted small-molecule tyrosine kinase inhibitors

Professor Elnur Sahibov is a radiation oncology specialist at Emsey Hospital who focuses on targeted treatment for gynaecological malignancies.

• Trained at Marmara University Faculty of Medicine – a leading Turkish academic medical centre
• Specialises in radiation oncology for treating tumours of the reproductive system
• Uses English-language medical protocols to manage complex oncological cases
• Focuses on precise radiation delivery to target cancer cells while sparing healthy tissue